Jaundice, Neonatal Clinical Trial
Official title:
Clinical Efficacy of LED Phototherapy Devices With Blue - Green Versus Blue Light of Equal Irradiance in Neonates With Non Hemolytic Jaundice
Phototherapy is the most frequently used treatment in neonatology when serum bilirubin levels exceed physiological limits. Light-emitting diodes (LEDs) are become routinely used for phototherapy in neonates with hyperbilirubinemia. Blue LED light with peak emission around 460 nm is regarded as the most suitable light sources for phototherapy and they recommended by most neonatal guidelines. However, the effectiveness of phototherapy with narrow-band LED light sources can be increased by expanding the spectral range of incident radiation within the absorption of bilirubin due to the strongly marked heterogeneity absorption properties of bilirubin in a different microenvironment. Longer wavelength light, such as green light, is expected to penetrate the infant's skin deeper. It is still controversial whether the use of green light has any advantage over blue light. The most effective and safest light source and the optimal method to evaluate phototherapy, however, remain unknown.The aim of this study was to compare, at equal light irradiance, the clinical efficacy of broad spectrum blue- green LED with blue narrow spectral band phototherapy device.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06186349 -
The Effect and Mechanism of Gene Variation on Neonatal Hyperbilirubinemia
|
||
| Recruiting |
NCT04369313 -
Effect of DCC on Neonatal Jaundice and Blood Gas Analysis in Infants Born to GDM Mothers
|
N/A | |
| Not yet recruiting |
NCT04585828 -
Comparison of Double Pad Fiber Optic Device Versus Conventional Phototherapy
|
N/A | |
| Completed |
NCT02927093 -
Clinical and Developmental Outcomes of Babies Who Became Yellow in the First Month of Life
|
N/A | |
| Unknown status |
NCT01340339 -
Reverse Phototherapy With Super Light-emitting Diode(Super-LED) for Hyperbilirubinemia in Term and Late Preterm Infants
|
Phase 4 | |
| Completed |
NCT02033096 -
Observational Follow-up of Participants From Clinical Trial 64,185-202 (NCT00850993)
|
||
| Recruiting |
NCT04218318 -
Safe Threshold to Discontinue Phototherapy in Hemolytic Disease of Newborn
|
N/A | |
| Active, not recruiting |
NCT02602301 -
The Effect of Intravenous Oxytocin Infusion Using Different Diluents on Neonatal Bilirubin & Sodium Levels
|
Phase 4 | |
| Completed |
NCT00801619 -
Bilicurves: Using Information Technology to Improve the Management of Neonatal Hyperbilirubinemia
|
N/A | |
| Active, not recruiting |
NCT05343403 -
Parental Participation on the Neonatal Ward - the neoPARTNER Study
|
||
| Completed |
NCT03880591 -
Neonatal Hyperbilirubinaemia in the Democratic Republic of Congo
|
||
| Completed |
NCT01599611 -
Follow-up of Extreme Neonatal Hyperbilirubinemia in 5-10 Year Old Children: a Danish Population Based Study
|
N/A | |
| Recruiting |
NCT06399146 -
Evaluation of Bilirubin Estimates in Newborns From Smartphone Digital Images in a Population in Botswana
|
N/A | |
| Completed |
NCT06018012 -
MRA and ABR as Early Predictors of Bilirubin-Induced Neurologic Dysfunction in Full-term Jaundiced Neonates
|
||
| Completed |
NCT03536078 -
Home Phototherapy for Term Newborns With Icterus
|
N/A | |
| Withdrawn |
NCT00917007 -
Measurement of Carboxyhemoglobin by Gas Chromatography as an Index of Hemolysis
|
||
| Recruiting |
NCT00154960 -
Establishing Novel Detection Techniques for Various Genetic-Related Diseases by Applying DHPLC Platform.
|
N/A | |
| Recruiting |
NCT02594904 -
Efficacy of Yinzhihuang Oral Liquid on Indirect Bilirubin of Neonates With Glucose-6-phosphate Dehydrogenase Deficiency
|
Phase 4 | |
| Completed |
NCT01746511 -
Glycerin Suppositories to Reduce Jaundice in Premature Infants
|
N/A | |
| Completed |
NCT01470820 -
Dose-response Relationship of Phototherapy for Hyperbilirubinaemia Using Diodes: is There a "Saturation Point"
|
N/A |